|
시장보고서
상품코드
2078232
정맥 주사액 시장 : 용액별, 백 유형별, 용도별, 최종사용자별, 지역별 규모, 점유율, 전망 및 기회 분석(2025년-2032년)Intravenous Solutions Market, by Solution, by Bag Type, by Application, by End User, and by Region Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032 |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
정맥 주사액 시장은 2026년에 117억 7,000만 달러, 2033년까지 182억 9,000만 달러에 이를 것으로 예상됩니다. 또한, 2026-2033년 CAGR 6.5%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 117억 7,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 6.50% | 2033년 시장 규모 예측 : | 182억 9,000만 달러 |
정맥 주사액이란, 환자의 정맥 순환계에 직접 투여되는 액체를 말합니다. 이들은 정맥 내 투여용 단일 투여 용기에 담겨 있으며, 체액 보충 및 칼로리 공급을 목적으로 하는 무균 및 비발열성 용액입니다. 시장에는 염화나트륨, 링거액, 수용성 포도당액 등 다양한 유형의 정맥 주입액이 유통되고 있습니다. 정맥 내 요법은 영양 결핍이나 탈수 증상으로 고통받는 환자에게 이상적인 치료법입니다. 탈수 증상은 다음과 같은 다양한 영향을 초래할 수 있습니다.
- 체내의 중요한 미네랄(전해질)의 균형.
- 인지(정신) 기능.
- 에너지 수준.
- 위장 기능(음식을 소화하고 소변과 대변을 생성하는 능력).
- 두통의 빈도와 강도.
- 신체 능력.
- 피부의 건강 상태.
시장 역학
설사 유병률 증가로 인해, 예측 기간 동안 전 세계 정맥 주사 용액 시장의 성장이 촉진될 것으로 예측됩니다. 예를 들어, 2022년 7월, 전 세계 어린이들에게 인도적 지원 및 개발 원조를 제공하는 유엔 기관인 유니세프(유엔아동기금)는 2020년 전 세계 5세 미만 아동 사망의 9%가 설사로 인한 것이었습니다고 밝힌 보고서를 발표했습니다. 또한, 설사로 인해 매일 1,300명 이상의 유아가 사망하고 있으며, 전 세계적으로 매년 약 48만 4,000명의 어린이가 설사로 목숨을 잃고 있다고 합니다.
또한, 2018년 9월 『란셋 감염병(The Lancet Infectious Diseases)』지에 게재된 기사에 따르면, 2016년 기준 설사는 장애 조정 생명년(DALY)의 세 번째로 큰 원인이었으며, 전 세계적으로 7,440만 DALY를 차지했습니다. 해당 자료에 따르면, 설사는 사망 원인 중 8위를 차지하며, 2016년에는 전 세계적으로 165만 5,944명이 사망했습니다.
본 조사의 주요 특징:
- 본 조사에서는 다양한 부문에서 잠재적인 수익 기회를 규명하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 재무 실적, 제품 포트폴리오, 사업 전개 지역, 유통 전략, 주요 발전 사항 및 전략)를 바탕으로 전 세계 정맥 주사액 시장의 주요 기업 프로파일을 소개했습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 정부의 정책, 기술 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- "세계 정맥 주사액 시장” 보고서는 투자자, 제품 제조업체, 유통업체, 공급업체, 조사·컨설팅 회사, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 정맥 주사액 시장을 분석하는 데 사용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 정맥 주사액 시장 : 솔루션별, 2021년-2033년
제5장 세계의 정맥 주사액 시장 : 백 유형별, 2021년-2033년
제6장 세계의 정맥 주사액 시장 : 용도별, 2021년-2033년
제7장 세계의 정맥 주사액 시장 : 최종사용자별, 2021년-2033년
제8장 세계의 정맥 주사액 시장 : 지역별, 2021년-2033년
제9장 경쟁 구도
제10장 애널리스트의 제안
제11장 섹션
LSH 26.07.10Intravenous Solutions Market is estimated to be valued at USD 11.77 Bn in 2026 and is expected to reach USD 18.29 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 11.77 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.50% | 2033 Value Projection: | USD 18.29 Bn |
Intravenous solutions are fluids, which are administrated to a patient directly into the venous circulation. These fluids are sterile, non-pyrogenic solutions used for fluid replenishment and caloric supply in single dose container for intravenous administration. There are various types of intravenous solutions available in the market such as sodium chloride, lactated ringers, dextrose in water, and others. Intravenous therapy is ideal for patients suffering from nutritional deficiency and dehydration. Dehydration can contribute to various affects such as
- Balance of important minerals (electrolytes) in the body.
- Cognitive (mental) performance.
- Energy level.
- Gastrointestinal function (your ability to digest food and create pee and poop).
- Headache frequency and intensity.
- Physical performance.
- Skin health.
Market Dynamics
Increasing prevalence of diarrhoea is expected to boost the global intravenous solution market growth over the forecast period. For instance, in July 2022, UNICEF (United Nations International Children's Emergency Fund), an agency of the United Nations responsible for providing humanitarian and developmental aid to children worldwide, published a report which accounted for 9 per cent of all deaths among children under age 5 worldwide in 2020 due to Diarrhoea, whereas over 1,300 young children dying each day, or about 484,000 children a year globally due to diarrhoea.
Moreover, according to an article published in the Lancet Infectious Diseases, September 2018, diarrhoea was the third leading cause of disability-adjusted life year (DALYs) in 2016, which accounted for 74.4 million DALYs, globally. According to the same source, diarrhoea was the eighth leading cause of death, which accounted for 1,655,944 deaths in 2016 globally.
Key features of the study:
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
- It profiles key players in the global intravenous solutions market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include, Baxter International Inc. ICU Medical, Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited, Pfizer, Inc, Otsuka Pharmaceutical Co., Ltd, Ajinomoto Co., Inc., B. Braun Melsungen AG, Soxa Formulations & Research Pvt.Ltd, Sichuan Kelun Pharmaceutical Co Ltd.
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global intravenous solutions market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global intravenous solutions market.
Detailed Segmentation:
- Global Intravenous Solutions Market, By Solution type (Revenue, USD Bn, 2021 - 2033)
- Saline
- Normal Saline (0.9% NaCl)
- Hypertonic Saline
- Dextran
- Lactated Ringer's
- Amino Acid
- Vitamins & Minerals
- Heparin and Trace Elements
- Mixed Solutions
- Global Intravenous Solutions Market, By Bag type (Revenue, USD Bn, 2021 - 2033)
- Large Volume Bags (greater than 250ml)
- Small Volume Bags (less than 250ml)
- Global Intravenous Solutions Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Basic IV Solution
- Nutritional IV Solution
- Blood IV Solution
- Drug IV Solution
- Irrigation IV Solution
- Global Intravenous Solutions Market, By End User (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- Home Care Settings
- Global Intravenous Solutions Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- By Country
- U.S.
- Canada
- By Country
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country
- Europe
- By Country
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- By Country
- Asia Pacific
- By Country
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- By Country
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- By Country
- Africa
- By Country
- South Africa
- Central Africa
- North Africa
- By Country
- Company Profiles
- Baxter International Inc.*
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- ICU Medical, Inc.
- Braun Melsungen Ag
- Grifols, S.A.
- Fresenius Kabi USA, LLC
- Vifor Pharma Management Ltd.
- JW Life Science
- Amanta Healthcare
- Axa Parenterals Ltd.
- Salius Pharma Private Limited.
- Pfizer, Inc.
- Otsuka Pharmaceutical Co., Ltd
- Ajinomoto Co., Inc.
- Braun Melsungen AG
- Soxa Formulations & Research Pvt.Ltd
- Sichuan Kelun Pharmaceutical Co Ltd
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Solution
- Market Snapshot, By Bag Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Epidemiology
- Porter's Five Forces Analysis
4. Global Intravenous Solutions Market, By Solution, 2021 - 2033, (US$ Billion)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Saline
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Normal Saline (0.9% NaCl)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Hypertonic Saline
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Dextran
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Lactated Ringer's
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Amino Acid
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Vitamins & Minerals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Heparin and trace elements
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Mixed Solutions
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
5. Global Intravenous Solutions Market, By Bag Type, 2021 - 2033, (US$ Billion)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Large Volume Bags (greater than 250ml)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Small Volume Bags (less than 250ml)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
6. Global Intravenous Solutions Market, By Application, 2021 - 2033, (US$ Billion)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Basic IV Solution
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Nutritional IV Solution
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Blood IV Solution
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Drug IV Solution
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Irrigation IV Solution
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
7. Global Intravenous Solutions Market, By End User, 2021 - 2033, (US$ Billion)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Ambulatory Surgery Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Home care Settings
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
8. Global Intravenous Solutions Market, By Region, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Solution, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Solution, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Solution, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Solution, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Solution, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Solution, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Billion)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Heat Map Analysis
- Company Profile
- Baxter International Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- ICU Medical, Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- B. Braun Melsungen Ag
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Grifols, S.A
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Fresenius Kabi USA, LLC
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Vifor Pharma Management Ltd.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- JW Life Science
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Amanta Healthcare
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Axa Parenterals Ltd
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Salius Pharma Private Limited.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Pfizer, Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Otsuka Pharmaceutical Co., Ltd
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Ajinomoto Co., Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Soxa Formulations & Research Pvt. Ltd
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Sichuan Kelun Pharmaceutical Co Ltd
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Baxter International Inc.
10. Analyst Recommendation
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. Section
- References
- Research Methodology
- About Us and Sales Contact
